hypertension - HealthQuill

More than 1,000 people globally die of strokes and heart attacks every hour, mostly due to high blood pressure, an official of not-for-profit, Resolve to Save Lives, said.

‘Every hour 1,000 people die of stroke, heart attack due to high blood pressure’

HQ Team September 19, 2023: More than 1,000 people globally die of strokes and heart attacks every hour, mostly due to high blood.

by HealthQuill
September 19, 2023
0 Comments

Johnson & Johnson has decided to halt an experimental trial, in its final stages, on a drug to treat a form of hypertension, according to a company statement.

Drugs Health Pharma

J&J halts final phase of trials of a drug to treat hypertension, says “futile”

HQ Team September 7, 2023: Johnson & Johnson has decided to halt an experimental trial, in its final stages, on a drug to.

by HealthQuill
September 7, 2023
0 Comments

Japan’s radiologists using chest radiographs developed an AI model to accurately predict a human’s chronological age and detect chronic diseases.

Drugs Health Pharma

Japan’s radiologists invent AI model to predict age from chest graphs

HQ Team August 18, 2023: Japan’s radiologists using chest radiographs developed an AI model to accurately predict a human’s chronological age and detect.

by HealthQuill
August 18, 2023
0 Comments

Switzerland’s healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to treat hypertension in people with high cardiovascular risk.

Drugs Health Pharma

Roche, Alnylam to jointly develop hypertension therapy

HQ Team July 25, 2023: Switzerland’s healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to.

by HealthQuill
July 25, 2023
0 Comments

AstraZeneca, a British-Swedish global pharmaceutical and biotechnology company, will buy CinCor Pharma, Inc., for $1.8 billion, according to a statement.

Drugs Pharma

AstraZeneca to acquire US-based CinCor for $1.8 billion

AstraZeneca, a British-Swedish global pharmaceutical and biotechnology company, will buy CinCor Pharma, Inc., for $1.8 billion, according to a statement.